Erythromycin estolate, CAS 3521-62-8

Product Description: Erythromycin estolate, erythromycin derivative[1], is a macrolide antibiotic used in the treatment of a wide variety of bacterial infections. Erythromycin estolate causes several cases of liver injury which mostly include cholestatic hepatitis. Erythromycin estolate toxicity is related to its inhibitory effect on bile acid transport[2].

Applications: COVID-19-immunoregulation

Formula: C52H97NO18S

References: [1]David E. Kleiner, et al. Learn more about Erythromycin Estolate. Biomaterials and Medical Device - Associated Infections, 2015/[2]Lu X, et al. Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat. Food Chem Toxicol. 2014 Mar;65:343-55.

CAS Number: 3521-62-8

Molecular Weight: 1056.39

Compound Purity: 98.98

Research Area: Infection

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: Bacterial

• Artikelnummer: MEXHY-N7121-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-N7121-10.1
• Green Labware: Nein
• Verpackungseinheit: 10mM/1mL
• Mengeneinheit: STK